Cargando…
Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
Biomarkers are rapidly gaining importance in personalized medicine. Although numerous molecular signatures have been developed over the past decade, there is a lack of overlap and many biomarkers fail to validate in independent patient cohorts and hence are not useful for clinical application. For t...
Autores principales: | Kim, Yunee, Jeon, Jouhyun, Mejia, Salvador, Yao, Cindy Q, Ignatchenko, Vladimir, Nyalwidhe, Julius O, Gramolini, Anthony O, Lance, Raymond S, Troyer, Dean A, Drake, Richard R, Boutros, Paul C, Semmes, O. John, Kislinger, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931234/ https://www.ncbi.nlm.nih.gov/pubmed/27350604 http://dx.doi.org/10.1038/ncomms11906 |
Ejemplares similares
-
Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma
por: Neely, Benjamin A., et al.
Publicado: (2016) -
Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer
por: Yang, Lifang, et al.
Publicado: (2015) -
Endoplasmic Reticulum Protein Targeting of Phospholamban: A Common Role for an N-Terminal Di-Arginine Motif in ER Retention?
por: Sharma, Parveen, et al.
Publicado: (2010) -
Targeted Identification of Metastasis-associated Cell-surface Sialoglycoproteins in Prostate Cancer
por: Yang, Lifang, et al.
Publicado: (2011) -
Optimization of small extracellular vesicle isolation from expressed prostatic secretions in urine for in‐depth proteomic analysis
por: Correll, Vanessa L., et al.
Publicado: (2022)